Suicide in People Aged 45-60: A Case-control Psychological Autopsy Study

December 3, 2021 updated by: University Ghent

Psychological Autopsy Study: A Case-control Research Into 45-60 Year Old Suicide Victims in Flanders, Belgium

The purpose of this study is to learn about the possible causes of the negative trend in suicide rates in both males and females aged 45-60 in Flanders, Belgium. This will be carried out using a psychological autopsy study.

Study Overview

Status

Completed

Conditions

Detailed Description

A case-control psychological autopsy study will be carried out to identify what risk factors are related to suicide in people aged 45-60. People close to the person who died by suicide (next of kin or close friends) will be interviewed. To increase the validity of our findings, a control group will also be interviewed. The control group will be someone who is very close to someone with mental health problems.

Study Type

Observational

Enrollment (Actual)

97

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ghent, Belgium, 9000
        • Unit for Suicide Research, Ghent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

community sample

Description

Inclusion Criteria:

  • close to suicide victim or person who has mental health problems
  • suicide victim or person with mental health problems was/is 45-60 years old
  • the suicide happened more than 3 months and less than 5 years ago

Exclusion Criteria:

  • not Dutch-speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Informants of suicide victims
Partners, children, parents, siblings, other relatives, peers or other informants of adults (aged 45-60 years) who received a definitive verdict of suicide in the Dutch-speaking part of Belgium (Flanders). The suicide should have taken place more than 3 months ago and less than 5 years ago.
Control group
Informants i.e., partners, children, parents, siblings, other relatives, peers or other informants of adults (aged 45-60 years) who have mental health problems.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Medical history
Time Frame: Baseline
Baseline
Sociodemographics
Time Frame: Baseline
Baseline
History of suicidal behaviour (presuicidal communication, method, intent)
Time Frame: baseline
baseline
Exposure to suicidal behavior
Time Frame: baseline
baseline
Living situation
Time Frame: Baseline
Baseline
Work situation
Time Frame: Baseline
Baseline
Religion
Time Frame: Baseline
Baseline
Interpersonal relationships (intimate, children, social contact, family)
Time Frame: Baseline
Baseline
Financial problems
Time Frame: Baseline
Baseline
Legal problems
Time Frame: Baseline
Baseline
Life events
Time Frame: Baseline
Baseline
Psychiatric history
Time Frame: Baseline
Baseline
Psychiatric disorders
Time Frame: Baseline
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kees van Heeringen, MD, PhD, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2018

Primary Completion (Actual)

December 9, 2019

Study Completion (Actual)

December 9, 2019

Study Registration Dates

First Submitted

September 27, 2018

First Submitted That Met QC Criteria

October 8, 2018

First Posted (Actual)

October 11, 2018

Study Record Updates

Last Update Posted (Actual)

December 6, 2021

Last Update Submitted That Met QC Criteria

December 3, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B670201836751

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide

3
Subscribe